Bird flu vaccine trial successful in Netherlands

Published 2023년 3월 17일

Tridge summary

Researchers at Wageningen University in the Netherlands have developed two vaccines that effectively protect chickens and turkeys from avian influenza, reducing both symptoms and virus transmission. These vaccines are part of a larger plan by the Dutch Ministry of Agriculture for a nationwide immunization of poultry farms, with trials set to expand to other facilities following successful initial outcomes. While not yet covered by European Union deposits, collaborations with EU members and sector representatives are anticipated for the vaccine's implementation across Europe, marking a significant advancement in combating the ongoing bird flu epidemic that has claimed over 5 million poultry in Europe since the past 1.5 years.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

As a result of studies carried out by the Wageningen University Faculty of Veterinary Medicine in the Netherlands, two vaccines were proven to be successful in protecting chickens against avian influenza. It was stated that the vaccines are effective not only against the symptoms of the disease, but also against the spread of the virus. Dutch Agriculture Minister Piet Adema, in his letter to the House of Representatives, said that the vaccine that protects chickens and turkeys from bird flu is an important step and the results are satisfactory. Europe has been battling the heaviest wave of bird flu for nearly 1.5 years. More than 5 million poultry were killed due to the epidemic. According to the information given by Dutch Agriculture Minister Piet Adema, Wageningen University experts tried four different vaccines against bird flu on chickens. Each vaccine was administered to 10 chickens. It was determined that the chickens in which two of the four vaccines were made did not get ...

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.